CN102286592A - 一种猪肺蛋白肽的制备方法 - Google Patents
一种猪肺蛋白肽的制备方法 Download PDFInfo
- Publication number
- CN102286592A CN102286592A CN2011102791579A CN201110279157A CN102286592A CN 102286592 A CN102286592 A CN 102286592A CN 2011102791579 A CN2011102791579 A CN 2011102791579A CN 201110279157 A CN201110279157 A CN 201110279157A CN 102286592 A CN102286592 A CN 102286592A
- Authority
- CN
- China
- Prior art keywords
- protein peptide
- filtrate
- pig lung
- preparation
- lung protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004072 lung Anatomy 0.000 title claims abstract description 101
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 68
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 67
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 67
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 235000015277 pork Nutrition 0.000 title abstract 9
- 239000012528 membrane Substances 0.000 claims abstract description 39
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 34
- 239000007788 liquid Substances 0.000 claims abstract description 26
- 229920000669 heparin Polymers 0.000 claims abstract description 20
- 239000002699 waste material Substances 0.000 claims abstract description 19
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims abstract description 18
- 229960001008 heparin sodium Drugs 0.000 claims abstract description 18
- 238000000605 extraction Methods 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 11
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 claims abstract description 5
- 239000000706 filtrate Substances 0.000 claims description 46
- 239000000203 mixture Substances 0.000 claims description 20
- 238000010521 absorption reaction Methods 0.000 claims description 19
- 239000011347 resin Substances 0.000 claims description 19
- 229920005989 resin Polymers 0.000 claims description 19
- 108091005804 Peptidases Proteins 0.000 claims description 11
- 102000035195 Peptidases Human genes 0.000 claims description 11
- 238000010612 desalination reaction Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000001694 spray drying Methods 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000000502 dialysis Methods 0.000 claims description 4
- 238000001976 enzyme digestion Methods 0.000 claims description 4
- 230000003053 immunization Effects 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 25
- 241001465754 Metazoa Species 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 8
- 238000012545 processing Methods 0.000 abstract description 8
- 238000000926 separation method Methods 0.000 abstract description 5
- 238000011033 desalting Methods 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000004071 biological effect Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 241000282898 Sus scrofa Species 0.000 description 81
- 235000018102 proteins Nutrition 0.000 description 53
- 238000012360 testing method Methods 0.000 description 38
- 239000000047 product Substances 0.000 description 8
- 108010006035 Metalloproteases Proteins 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 102000015636 Oligopeptides Human genes 0.000 description 5
- 108010038807 Oligopeptides Proteins 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 4
- 108090000145 Bacillolysin Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000035092 Neutral proteases Human genes 0.000 description 4
- 108091005507 Neutral proteases Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000003456 ion exchange resin Substances 0.000 description 4
- 229920003303 ion-exchange polymer Polymers 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 102000004506 Blood Proteins Human genes 0.000 description 3
- 108010017384 Blood Proteins Proteins 0.000 description 3
- 241000710778 Pestivirus Species 0.000 description 3
- -1 Xie Ansuan Chemical compound 0.000 description 3
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000000527 lymphocytic effect Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000006035 Tryptophane Substances 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000014590 basal diet Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 210000005104 human peripheral blood lymphocyte Anatomy 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000000072 sodium resin Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000021139 traditional diet Nutrition 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110279157.9A CN102286592B (zh) | 2011-09-20 | 2011-09-20 | 一种猪肺蛋白肽的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110279157.9A CN102286592B (zh) | 2011-09-20 | 2011-09-20 | 一种猪肺蛋白肽的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102286592A true CN102286592A (zh) | 2011-12-21 |
CN102286592B CN102286592B (zh) | 2014-03-26 |
Family
ID=45333346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110279157.9A Expired - Fee Related CN102286592B (zh) | 2011-09-20 | 2011-09-20 | 一种猪肺蛋白肽的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102286592B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103601822A (zh) * | 2013-11-20 | 2014-02-26 | 南通天龙畜产品有限公司 | 粗品肝素钠生产过程中肠渣的处理方法 |
CN103626836A (zh) * | 2012-08-21 | 2014-03-12 | 丰都泓乾生物科技有限公司 | 一种从粗品肝素钠生产废液中提取多肽的工艺 |
CN103951768A (zh) * | 2014-04-29 | 2014-07-30 | 贵州慧静生物科技有限公司 | 利用猪、牛肺提取肝素钠并联产多肽蛋白粉、氨基酸蛋白粉的方法 |
CN104498553A (zh) * | 2014-12-20 | 2015-04-08 | 山东绅联生物科技有限公司 | 一种从提取肝素钠废液中提取氨基酸粗品的方法 |
CN106317259A (zh) * | 2016-09-19 | 2017-01-11 | 陈石良 | 一种从猪肺中提取肝素钠和蛋白肽粉的联产工艺 |
CN114807279A (zh) * | 2022-05-18 | 2022-07-29 | 湖北瑞邦生物科技有限公司 | 一种富硒抗氧化猪肺多肽粉的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1661038A (zh) * | 2004-12-30 | 2005-08-31 | 上海三生生物技术有限公司 | 牛乳酶解蛋白多肽的制作方法 |
CN101659714A (zh) * | 2009-09-22 | 2010-03-03 | 石欣 | 一种提取肝素钠并联产氨基酸的方法 |
CN102178050A (zh) * | 2011-04-06 | 2011-09-14 | 安徽宝迪肉类食品有限公司 | 利用生产肝素钠残液制备肠膜蛋白粉的工艺 |
-
2011
- 2011-09-20 CN CN201110279157.9A patent/CN102286592B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1661038A (zh) * | 2004-12-30 | 2005-08-31 | 上海三生生物技术有限公司 | 牛乳酶解蛋白多肽的制作方法 |
CN101659714A (zh) * | 2009-09-22 | 2010-03-03 | 石欣 | 一种提取肝素钠并联产氨基酸的方法 |
CN102178050A (zh) * | 2011-04-06 | 2011-09-14 | 安徽宝迪肉类食品有限公司 | 利用生产肝素钠残液制备肠膜蛋白粉的工艺 |
Non-Patent Citations (1)
Title |
---|
张昌敬 等: "猪肺的价值与生化制备", 《重庆师范学院学报(自然科学版)》 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103626836A (zh) * | 2012-08-21 | 2014-03-12 | 丰都泓乾生物科技有限公司 | 一种从粗品肝素钠生产废液中提取多肽的工艺 |
CN103601822A (zh) * | 2013-11-20 | 2014-02-26 | 南通天龙畜产品有限公司 | 粗品肝素钠生产过程中肠渣的处理方法 |
CN103601822B (zh) * | 2013-11-20 | 2015-11-25 | 南通天龙畜产品有限公司 | 粗品肝素钠生产过程中肠渣的处理方法 |
CN103951768A (zh) * | 2014-04-29 | 2014-07-30 | 贵州慧静生物科技有限公司 | 利用猪、牛肺提取肝素钠并联产多肽蛋白粉、氨基酸蛋白粉的方法 |
CN103951768B (zh) * | 2014-04-29 | 2016-05-11 | 贵州慧静生物科技有限公司 | 利用猪、牛肺提取肝素钠并联产多肽蛋白粉、氨基酸蛋白粉的方法 |
CN104498553A (zh) * | 2014-12-20 | 2015-04-08 | 山东绅联生物科技有限公司 | 一种从提取肝素钠废液中提取氨基酸粗品的方法 |
CN104498553B (zh) * | 2014-12-20 | 2018-06-19 | 山东绅联生物科技有限公司 | 一种从提取肝素钠废液中提取氨基酸粗品的方法 |
CN106317259A (zh) * | 2016-09-19 | 2017-01-11 | 陈石良 | 一种从猪肺中提取肝素钠和蛋白肽粉的联产工艺 |
CN114807279A (zh) * | 2022-05-18 | 2022-07-29 | 湖北瑞邦生物科技有限公司 | 一种富硒抗氧化猪肺多肽粉的制备方法 |
CN114807279B (zh) * | 2022-05-18 | 2024-05-14 | 湖北瑞邦生物科技有限公司 | 一种富硒抗氧化猪肺多肽粉的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102286592B (zh) | 2014-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102286592B (zh) | 一种猪肺蛋白肽的制备方法 | |
CN102732589B (zh) | 一种苏氨酸母液处理的方法 | |
EP2823714B1 (en) | Method for producing low-ash poultry plasma protein powder by utilizing poultry blood | |
CN102010459B (zh) | 一种畜禽血浆蛋白粉的制备方法 | |
CN102643209B (zh) | 一种l-谷氨酰胺的提取方法 | |
CN102630804A (zh) | 一种核桃肽粉的生产工艺 | |
CN111642730B (zh) | 一种酱油渣循环洗脱利用方法、产物及设备 | |
CN103030645A (zh) | 一种大规模制备高纯度血红素的方法及应用 | |
Türker et al. | Waste (water) to feed protein: Effluent characteristics, protein recovery, and single-cell protein production from food industry waste streams | |
CN109957045A (zh) | 一种从动物肝脏中提取肝素钠和蛋白肽的联产工艺 | |
CN103232354B (zh) | 一种从缬氨酸发酵液中分离杂酸的方法 | |
CN101748179B (zh) | 一种羽毛蛋白肽的制备方法 | |
CN103876163A (zh) | 一种林蛙肉复合蛋白粉及其制备方法 | |
CN101849612A (zh) | 一种鸡血血浆蛋白粉的制备工艺 | |
CN103005218A (zh) | 一种猪饲料及其制备方法 | |
CN103224454B (zh) | 一种谷氨酸的分离提取工艺 | |
CN101548709A (zh) | 动物血液蛋白胨及其加工工艺 | |
CN103349151A (zh) | 从猪小肠粘膜中提取多肽蛋白粉的方法 | |
CN104313105A (zh) | 一种利用苏氨酸发酵液及废母液制备65%苏氨酸的方法 | |
CN108101980B (zh) | 一种高纯度藻蓝色素的制备方法 | |
CN105596370A (zh) | 一种驼血多肽的制备方法 | |
CN105154505A (zh) | 一种饲料级海洋鱼低聚肽粉的制备方法 | |
CN102277403B (zh) | 酶法提取黄酒糟蛋白生产工艺 | |
CN108624642A (zh) | 一种从猪肺中提取高品质蛋白肽的制备方法 | |
CN103005219B (zh) | 一种母猪饲料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20181010 Granted publication date: 20140326 |
|
PD01 | Discharge of preservation of patent |
Date of cancellation: 20181105 Granted publication date: 20140326 |
|
PD01 | Discharge of preservation of patent | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200903 Address after: 201210 Shanghai city Pudong New Area Cailun Road No. 88 Patentee after: SHANGHAI TRANSGENIC RESEARCH CENTER Address before: 201300 Shanghai city Pudong New Area Town Road No. 22 Xuan Xuan Patentee before: Shanghai Genon Biological Product Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140326 |
|
CF01 | Termination of patent right due to non-payment of annual fee |